The prevalence of mental health illness among patients with HIV is a significant public health issue. The translation of discoveries found at the bench to clinical practice (bench to bedside) is critical for advancements in diagnosing and therapeutic intervention to be made. This relationship, however, is not a one-way street, but bi-directional, where observations made in a clinical setting may also stimulate research at the bench. As such, it is important to develop a collaborative, multi-disciplinary community of clinicians and scientists to foster new discoveries with practical application in diagnosing and treating HIV+ persons with neuropsychological illness. To address this need, the Clinical and Behavioral Core will assist basic and clinical investigators wishing to include human subjects from a well-characterized cohort of HIV+ individuals in their studies, including those assessed for neuropsychological function. We will assist new and established investigators in the design and coordination of their studies, the preparation of required forms and approvals and data collection. To achieve this, the Clinical and Behavioral Core will have three primary functions: 1.) Provide the clinical cohort from the Temple Comprehensive HIV program with its infrastructure, operations management and regulatory oversight for clinical studies involving other CNACC cores or non-CNACC clinical collaborators, 2.) Systematically collect baseline and longitudinal neurocognitive, neurologic and psychiatric assessments on patients in Temple's HIV practice in collaboration with the Department of Psychiatry (for our revised application, we have included an expert neuropsychologist with HIV/AIDS neurocognitive testing and analysis experience, recently hired by Temple University Hospital (Dr. Nancy Minniti) and a consultant with internationally recognized expertise in neurocognitive testing, Dr. Kevin Robertson from the University of North Carolina.), and 3.) Develop and maintain a neurodatabase that will contain data from assessments in function #2, as well as relevant immunologic and virologic data from the Temple HIV clinical database and other studies conducted through CNACC.
This core enables the integration of basic science investigations with clinical populations to further the aims of neuroscience translational research and expand opportunities for cross-disciplinary studies in epidemiology, public health and behavioral medicine. The core research activities foster the evaluation and application of novel targets and therapies in the management and care of HIV infected patients.
|Wang, Jin Ying; Darbinyan, Armine; White, Martyn K et al. (2014) Involvement of IRS-1 interaction with ADAM10 in the regulation of neurite extension. J Cell Physiol 229:1039-46|
|Dahiya, Satinder; Liu, Yujie; Nonnemacher, Michael R et al. (2014) CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage. PLoS One 9:e88116|
|Palma, Jonathan; Abood, Mary E; Barbe, Mary F et al. (2014) Functional interaction between HIV-gp120 and opioid system in the preoptic anterior hypothalamus. Drug Alcohol Depend 134:383-6|
|White, Martyn K; Kaminski, Rafal; Khalili, Kamel et al. (2014) Rad51 activates polyomavirus JC early transcription. PLoS One 9:e110122|
|Pozniak, Paul D; White, Martyn K; Khalili, Kamel (2014) TNF-*/NF-*B signaling in the CNS: possible connection to EPHB2. J Neuroimmune Pharmacol 9:133-41|
|Gill, Alexander J; Kovacsics, Colleen E; Cross, Stephanie A et al. (2014) Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. J Clin Invest 124:4459-72|
|Strazza, Marianne; Banerjee, Anupam; Alexaki, Aikaterini et al. (2014) Effect of ?-opioid agonist DAMGO on surface CXCR4 and HIV-1 replication in TF-1 human bone marrow progenitor cells. BMC Res Notes 7:752|
|Fischer, Tracy; Wyatt, Christina M; D'Agati, Vivette D et al. (2014) Mononuclear phagocyte accumulation in visceral tissue in HIV encephalitis: evidence for increased monocyte/macrophage trafficking and altered differentiation. Curr HIV Res 12:201-12|
|Aiamkitsumrit, Benjamas; Dampier, Will; Martin-Garcia, Julio et al. (2014) Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences. PLoS One 9:e107389|
|Hu, Wenhui; Kaminski, Rafal; Yang, Fan et al. (2014) RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proc Natl Acad Sci U S A 111:11461-6|
Showing the most recent 10 out of 17 publications